Anti-ACTL8 antibody [EPR13912]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal ACTL8 antibody. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 2 publications.
View Alternative Names
Actin-like protein 8, Cancer/testis antigen 57, CT57, ACTL8
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-ACTL8 antibody [EPR13912] (AB184562)
Intracellular flow cytometric analysis of HeLa cells (paraformaldehyde-fixed, 2%) labeling ACTL8 with ab184562 at 1/160 dilution (red) or a rabbit IgG (negative) (green), followed by Goat anti rabbit IgG (FITC) secondary at 1/150 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-ACTL8 antibody [EPR13912] (AB184562)
Western blot analysis of immunoprecipitation pellet from HeLa cell lysate (lane 1) or PBS (lane 2) immunoprecipitated using ab184562 at 1/50 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG secondary antibody used at 1/1500 dilution.
All lanes:
Immunoprecipitation - Anti-ACTL8 antibody [EPR13912] (ab184562)
Predicted band size: 41 kDa
true
- WB
Supplier Data
Western blot - Anti-ACTL8 antibody [EPR13912] (AB184562)
All lanes:
Western blot - Anti-ACTL8 antibody [EPR13912] (ab184562) at 1/2000 dilution
All lanes:
Human testis lysate at 20 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 41 kDa
true
- WB
Supplier Data
Western blot - Anti-ACTL8 antibody [EPR13912] (AB184562)
All lanes:
Western blot - Anti-ACTL8 antibody [EPR13912] (ab184562) at 1/2000 dilution
Lane 1:
HeLa cell lysate at 20 µg
Lane 2:
HepG2 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 41 kDa
true
Related conjugates and formulations (8)
-
Anti-ACTL8 antibody [EPR13912] - BSA and Azide free
-
578 PE
PE Anti-ACTL8 antibody [EPR13912]
-
660 APC
APC Anti-ACTL8 antibody [EPR13912]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-ACTL8 antibody [EPR13912]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-ACTL8 antibody [EPR13912]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-ACTL8 antibody [EPR13912]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-ACTL8 antibody [EPR13912]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-ACTL8 antibody [EPR13912]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Actin-Like 8 participates in intracellular transport and cell shape changes. It doesn't appear to form part of a well-defined complex but it may interact with other actin-related proteins and myosins in the testis. Its function is important in the development and maintenance of sperm tail structure suggesting a role in spermatogenesis.
Pathways
ACTL8 is involved in actin cytoskeleton remodeling pathways. It connects to the Wnt signaling pathway which influences cell proliferation and differentiation. ACTL8 may interact with proteins like beta-catenin that bridge Wnt signaling and cytoskeletal organization which is important for cellular adhesion and migration processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
OncoTargets and therapy 14:2463-2473 PubMed33883901
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 52:1209-1223 PubMed29532865
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com